Cocaine Use
13
1
2
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.7%
1 terminated out of 13 trials
85.7%
-0.9% vs benchmark
8%
1 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (13)
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder
Treating Polysubstance Use Using a Novel Digital Technology
Intranasal Cocaine and Temperature Regulation During Exercise
Comparing Efficacy & Safety Of TNX-1300 To Placebo With UC For Treatment Of Acute Cocaine Intoxication In ED Subjects (CATALYST)
Change in Cognitive Function in Stimulant Users
Clinical and Atherosclerotic Characteristics of Patients With ACS Associated With Cocaine Use
Project SMART Automated Pillbox Study
Effect of rTMS on Neurotrophines Levels in CUD
L-tetrahydropalmatine (l-THP) Treatment for Cocaine Use Disorder
Pharmacokinetic and Safety Evaluation of L-tetrahydropalmatine (l-THP) With Cocaine Exposure in People With a History of Cocaine Use
Pilot Study of Repetitive Transcranial Magnetic Stimulation in Cocaine Craving
Interactions Between Intravenous Cocaine and Acetazolamide or Quinine